Recurrent Glioblastoma Multiforme

DrugDrug NameDrug Description
DB00262CarmustineA cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
DrugDrug NamePhaseStatusCount
DB11666Buparlisib1Completed1
DB00958Carboplatin1Completed1
DB01206Lomustine1Completed1
DB09143Sonidegib1Completed1
DB023422-Methoxyestradiol2Completed2
DB00112Bevacizumab2Completed2
DB00762Irinotecan2Unknown Status1
DB01206Lomustine2Unknown Status1
DB05931Pegdinetanib2Unknown Status1
DB01168Procarbazine2Unknown Status1
DB00398Sorafenib2Completed1
DB00853Temozolomide2Completed3
DB02546Vorinostat2Completed1